AU2001269291A1 - Therapeutic acridone and acridine compounds - Google Patents
Therapeutic acridone and acridine compoundsInfo
- Publication number
- AU2001269291A1 AU2001269291A1 AU2001269291A AU6929101A AU2001269291A1 AU 2001269291 A1 AU2001269291 A1 AU 2001269291A1 AU 2001269291 A AU2001269291 A AU 2001269291A AU 6929101 A AU6929101 A AU 6929101A AU 2001269291 A1 AU2001269291 A1 AU 2001269291A1
- Authority
- AU
- Australia
- Prior art keywords
- acridone
- therapeutic
- acridine compounds
- acridine
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- GDALETGZDYOOGB-UHFFFAOYSA-N Acridone Natural products C1=C(O)C=C2N(C)C3=CC=CC=C3C(=O)C2=C1O GDALETGZDYOOGB-UHFFFAOYSA-N 0.000 title 1
- 150000001251 acridines Chemical class 0.000 title 1
- FZEYVTFCMJSGMP-UHFFFAOYSA-N acridone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3NC2=C1 FZEYVTFCMJSGMP-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/06—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
- C07D219/10—Nitrogen atoms attached in position 9
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21662400P | 2000-07-07 | 2000-07-07 | |
| US60/216,624 | 2000-07-07 | ||
| PCT/GB2001/003046 WO2002008193A2 (en) | 2000-07-07 | 2001-07-06 | Therapeutic acridone and acridine compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001269291A1 true AU2001269291A1 (en) | 2002-02-05 |
Family
ID=22807812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001269291A Abandoned AU2001269291A1 (en) | 2000-07-07 | 2001-07-06 | Therapeutic acridone and acridine compounds |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US7160896B2 (en) |
| EP (1) | EP1363888A2 (en) |
| JP (1) | JP2004510706A (en) |
| AU (1) | AU2001269291A1 (en) |
| WO (1) | WO2002008193A2 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002008193A2 (en) * | 2000-07-07 | 2002-01-31 | Cancer Research Technology Limited | Therapeutic acridone and acridine compounds |
| CA2473170A1 (en) | 2002-01-15 | 2003-07-24 | Cancer Research Technology Limited | Therapeutic acridone and acridine compounds |
| GB0207623D0 (en) | 2002-04-02 | 2002-05-15 | Cancer Res Ventures Ltd | Crystal structure of g-quadruplex |
| US7109337B2 (en) | 2002-12-20 | 2006-09-19 | Pfizer Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
| GEP20084357B (en) | 2002-12-20 | 2008-04-29 | Pfizer Prod Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
| US20050249669A1 (en) * | 2003-10-22 | 2005-11-10 | Academia Sinica | Quadruplex stabilizer |
| US7691624B2 (en) * | 2003-10-22 | 2010-04-06 | Academia Sinica | Cancer cell detecting devices |
| MXPA06013165A (en) | 2004-05-14 | 2007-02-13 | Pfizer Prod Inc | Pyrimidine derivatives for the treatment of abnormal cell growth. |
| CA2566332A1 (en) | 2004-05-14 | 2005-11-24 | Pfizer Products Inc. | Pyrimidine derivatives for the treatment of abnormal cell growth |
| CA2566477A1 (en) | 2004-05-14 | 2005-11-24 | Pfizer Products Inc. | Pyrimidine derivatives for the treatment of abnormal cell growth |
| WO2006094207A2 (en) * | 2005-03-03 | 2006-09-08 | St. Jude Children's Research Hospital | Substituted phenoxazines and acridones as inhibitors of akt |
| GB0505045D0 (en) * | 2005-03-11 | 2005-04-20 | Antisoma Plc | Cancer treatment |
| JP5782586B2 (en) | 2007-05-10 | 2015-09-24 | ドッグウッド ファーマシューティカルズ，インコーポレイテッド | Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and their use |
| US8618125B2 (en) | 2011-01-14 | 2013-12-31 | Heptiva LLC | Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance |
| CN105418501B (en) * | 2015-12-02 | 2018-04-17 | 广西中医药大学 | 7 pairs of anisidino- benzo [c] acridine hydrochlorides and its preparation method and application |
| CA3209229A1 (en) * | 2017-11-09 | 2019-05-16 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Compounds for inhibiting ly6k and methods of using same |
| US20230210841A1 (en) * | 2020-05-15 | 2023-07-06 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Compounds for inhibiting ly6k and methods of using same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE488890C (en) | 1924-09-12 | 1930-01-23 | I G Farbenindustrie Akt Ges | Process for the preparation of aminoalkylamino substitution products of the acridine series |
| AR011057A1 (en) | 1997-01-08 | 2000-08-02 | Smithkline Beecham Corp | USE OF SUBSTITUTED BIS-ACRIDINES AND RELATED COMPOUNDS FOR THE PREPARATION OF MEDICINES AND SUCH COMPOUNDS |
| WO2002008193A2 (en) * | 2000-07-07 | 2002-01-31 | Cancer Research Technology Limited | Therapeutic acridone and acridine compounds |
| CA2473170A1 (en) * | 2002-01-15 | 2003-07-24 | Cancer Research Technology Limited | Therapeutic acridone and acridine compounds |
-
2001
- 2001-07-06 WO PCT/GB2001/003046 patent/WO2002008193A2/en not_active Ceased
- 2001-07-06 US US10/332,261 patent/US7160896B2/en not_active Expired - Fee Related
- 2001-07-06 JP JP2002514100A patent/JP2004510706A/en not_active Withdrawn
- 2001-07-06 AU AU2001269291A patent/AU2001269291A1/en not_active Abandoned
- 2001-07-06 EP EP20010947645 patent/EP1363888A2/en not_active Withdrawn
-
2005
- 2005-06-22 US US11/157,977 patent/US7300930B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004510706A (en) | 2004-04-08 |
| EP1363888A2 (en) | 2003-11-26 |
| US7300930B2 (en) | 2007-11-27 |
| WO2002008193A2 (en) | 2002-01-31 |
| US20030207909A1 (en) | 2003-11-06 |
| US20060111389A1 (en) | 2006-05-25 |
| WO2002008193A3 (en) | 2003-10-02 |
| US7160896B2 (en) | 2007-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001295019A1 (en) | Integrated security system | |
| IL154618A0 (en) | Quinolinone derivatives | |
| EP1146790A4 (en) | Compounds and methods | |
| EP1223932A4 (en) | Compounds and methods | |
| AU2001280599A1 (en) | Compounds and methods | |
| AU2001253418A1 (en) | Compounds and methods | |
| AU2001269291A1 (en) | Therapeutic acridone and acridine compounds | |
| AU2002218502A1 (en) | Lactam compounds and medicinal use thereof | |
| AU2001243394A1 (en) | Compounds and methods | |
| PL370449A1 (en) | Therapeutic acridone and acridine compounds | |
| AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
| AUPQ872300A0 (en) | Compounds and methods | |
| AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
| AU2001278951A1 (en) | Compounds and methods | |
| AU6083501A (en) | Security device | |
| AU2002219176A1 (en) | Dihydroindole and tetrahydroquinoline derivatives | |
| AU1917602A (en) | Dihydroindole and tetrahydroquinoline derivatives | |
| AU4432001A (en) | Trityl-type compounds and their use | |
| AU2002235277A1 (en) | Compounds and methods | |
| AUPQ766000A0 (en) | Security device | |
| AU5555900A (en) | Security device | |
| AU2001240817A1 (en) | Security feature | |
| AU3442100A (en) | Security devices | |
| AU3020399A (en) | Security garment | |
| AU6884801A (en) | Therapeutic compounds and methods |